3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Hyperthermia
8
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Sarcoma
2
Ovarian Neoplasms
2
Carcinoma, Ovarian Epithelial
2
Breast Neoplasms
2
Unspecified Adult Solid Tumor, Protocol Specific
1
Sarcoma, Synovial
1
Sarcoma, Clear Cell
1
Sarcoma, Alveolar Soft Part
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Neurofibrosarcoma
1
Mesothelioma, Malignant
1
Melanoma
1
Liposarcoma, Myxoid
1
Liposarcoma
1
Leiomyosarcoma
1
Histiocytoma, Malignant Fibrous
1
Head and Neck Neoplasms
1
Fibrosarcoma
1
Fallopian Tube Neoplasms
1
Endometrial Neoplasms
1
Condylomata Acuminata
1
Breast Neoplasms, Male
1
Anus Neoplasms
1
Interventions
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
2
hecolin
1
Vaccination
1
Tuberculin
1
Trichloroacetic Acid
1
Podophyllin
1
PRA1 protein, Candida albicans
1
Measles-Mumps-Rubella Vaccine
1
Imiquimod
1
Ethanol
1
Diathermy
1
Cryotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Condylomata Acuminata
×
Diathermy
×
Clear all
NCT03289260
2020-09-23
AdAM
Medical University Innsbruck
Phase 3
Unknown
200 enrolled